Latest Industry Insights

Technology Networks spoke with Stefan Foser, vice president of global pharma at Bruker, to explore how they integrate instrumentation, software and consumables to support early-stage pharma innovation.

Explore how multiomics research combines genomics, proteomics, and transcriptomics to offer new insights in disease modeling and therapeutic advancements.

Weight loss isn’t just cosmetic; it prevents chronic disease, saves money and improves mental and physical well-being. Explore the latest weight loss research and learn how even moderate weight loss can transform metabolic health.

Learn how Bruker’s latest innovations are enhancing small molecule analysis for toxicology and environmental analysis.

In this interview, discover how Astoriom's Integrated Stability & Sustainability Outsourcing Model addresses traditional storage challenges and enables biopharma companies to respond more nimbly to disruptions.

Dr. Jennifer Schneider discusses Centauri Therapeutics' novel approach to combating Gram-negative infections, its first clinical candidate from the ABX-01 program and how the platform could help shape the future of anti-infective therapy.

Anti-infective discovery is evolving with AI and robotics – learn how UK researchers aim to cut development time and improve success rates.

We spoke with the developers and manufacturers of the CRISPR gene therapy used to treat KJ Muldoon’s rare genetic condition, CPS1, about how the product was created in just six months.

Novo Nordisk’s Transformational Prevention Unit (TPU) integrates AI, omics, and genomics to predict obesity risk and tailor interventions. By focusing on personalized solutions, TPU aims to prevent obesity and reduce the incidence of related diseases

In this interview, Morten Bern, chief executive officer of Evosep, discusses the innovations behind the Eno system, the evolving needs of pharmaceutical customers and the growing focus on high-throughput, high-sensitivity proteomics solutions.